- Home
- HUIZ vs CRIS Comparison
HUIZ vs CRIS Comparison
Compare HUIZ & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- CRIS
- Stock Information
- Founded
- HUIZ 2006
- CRIS 2000
- Country
- HUIZ China
- CRIS United States
- Employees
- HUIZ N/A
- CRIS N/A
- Industry
- HUIZ Specialty Insurers
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HUIZ Finance
- CRIS Health Care
- Exchange
- HUIZ Nasdaq
- CRIS Nasdaq
- Market Cap
- HUIZ 29.1M
- CRIS 31.2M
- IPO Year
- HUIZ 2020
- CRIS 2000
- Fundamental
- Price
- HUIZ $3.74
- CRIS $3.35
- Analyst Decision
- HUIZ
- CRIS Strong Buy
- Analyst Count
- HUIZ 0
- CRIS 3
- Target Price
- HUIZ N/A
- CRIS $23.00
- AVG Volume (30 Days)
- HUIZ 302.1K
- CRIS 74.2K
- Earning Date
- HUIZ 12-10-2024
- CRIS 02-06-2025
- Dividend Yield
- HUIZ N/A
- CRIS N/A
- EPS Growth
- HUIZ N/A
- CRIS N/A
- EPS
- HUIZ 0.29
- CRIS N/A
- Revenue
- HUIZ $170,927,079.00
- CRIS $10,259,000.00
- Revenue This Year
- HUIZ N/A
- CRIS N/A
- Revenue Next Year
- HUIZ $10.46
- CRIS N/A
- P/E Ratio
- HUIZ $10.21
- CRIS N/A
- Revenue Growth
- HUIZ N/A
- CRIS 0.44
- 52 Week Low
- HUIZ $0.43
- CRIS $3.05
- 52 Week High
- HUIZ $10.58
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- HUIZ 58.54
- CRIS 27.27
- Support Level
- HUIZ $2.60
- CRIS $3.75
- Resistance Level
- HUIZ $3.06
- CRIS $4.25
- Average True Range (ATR)
- HUIZ 0.94
- CRIS 0.33
- MACD
- HUIZ 0.04
- CRIS -0.07
- Stochastic Oscillator
- HUIZ 24.01
- CRIS 2.14
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.